Attention!

This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical of pharmaceutical specialist?

Report an adverse reaction

Generium Pharmaceuticals

The leader in the Russian orphan pharmaceutical market

Пропустить

Our R&D park is capable to handle the full cycle of development of any medication from molecule design to commercial production. We primarily focus of rare diseases that lack due therapy.

Generium Pharmaceuticals

Quality control at every stage

Пропустить

We control the quality of the medications throughout the entire life cycle of preparation. Not only industrial production meets GMP requirements. Development, preclinical and scientific research are carried out in strict accordance with international quality standards GLP and GCP.

Generium Pharmaceuticals

Cutting edge technologies

Пропустить

Scientific research is carried out together with biotechnological companies and scientific institutions from around the world

Generium Pharmaceuticals

Our ideas to save lives and health

Пропустить

We develop medications for the treatment of severe hereditary and life-threatening diseases.

Skip

Products

20
Skip
Elizaria®

Elizaria®

INN: eculizumab

More
Glurazyme®

Glurazyme®

INN: imiglucerase

More
Tigerase®

Tigerase®

INN: dornase alfa

More
Genolair®

Genolair®

INN: omalizumab

More
Revelise®

Revelise®

INN: alteplase

More
Infibeta®

Infibeta®

Infibeta® (interferon beta-1b) is a recombinant human interferon beta, belongs to a group of drugs that modify the course of multiple sclerosis.

More
Diaskintest®

Diaskintest®

Diaskintest® belongs to the IGRA group of tests, the latter being the most promising direction in the diagnosis of infectious diseases.

More
T-SPOT®.TB

T-SPOT®.TB

The T-SPOT®.TB test is a blood test to detect tuberculosis infection (TI) that is performed in one visit to a specialist.

More
Isotherm SARS-CoV-2-RNA-screen

Isotherm SARS-CoV-2-RNA-screen

Set of reagents for detection of SARS-CoV-2 RNA via loop isothermal amplification

More
Antigma®

Antigma®

Test systems for detecting antibodies to coronavirus SARS-CoV-2

More
MagniTest®

MagniTest®

A set of reagents for detecting SARS-CoV-2 RNA using loop isothermal amplification.

More
Coagil-VII®

Coagil-VII®

INN: eptacog alfa (activated)

More
TK-SMA

TK-SMA

TK-SMA is a reagent kit for the quantitative determination of TREC and KREC DNA and the qualitative detection of homozygous deletion of exon 7 of the SMN1 gene by real-time polymerase chain reaction (RT-PCR) in whole blood and dried blood spots.

More
Octofactor®

Octofactor®

INN: Moroctocog alfa

More
TigraTest SARS-CoV-2

TigraTest SARS-CoV-2

The study is based on the ELISPOT method, a proven technology for detecting active T cells to measure the strength of the immune response to infection.

More
Innonafactor®

Innonafactor®

INN: Nonacog alfa

More
IMMUNO-BIT

IMMUNO-BIT

The test is based on the quantitative determination of TREC and KREC DNA - markers of maturity and differentiation of T- and B-lymphocytes in whole blood or in dried blood spots using RT-PCR.

More
Laxolan®

Laxolan®

INN: ranimizumab

More
Stimplate®

Stimplate®

INN: romiplostim

More
Salnavac

Salnavac

Nasal vaccine.

More

Scientific institute and biotechnological production

  • Laboratories

    5 000 m2

  • Area exceeds

    80 Ha

  • Industrial facilities

    45 000 m2

  • Number of staff exceeds

    1 500 persons

Pipeline

More
  • Orphan diseases
  • Autoimmune diseases
Skip
Orphan diseases

GNR-055

MPS II, Hunter syndrome

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

GNR-062

Fabry disease (INN: agalsidase beta)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

GNR-071

Maroteaux-Lamy syndrome, Mucopolysaccharidosis type VI (INN: galsulfase)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация
Autoimmune diseases

GNR-068

Plaque psoriasis (interleukin inhibitor)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

GNR-086

Systemic juvenile idiopathic arthritis (INN: canakinumab)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

GNR-087

Rheumatoid arthritis (INN: tocilizumab)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

GNR-093

Multiple sclerosis (INN: natalizumab)

ДКИ
КИ I фазы
КИ II-III фазы
Регистрация

Contact information

Headquarters

Manufacturing and "R&D"

Headquarters

123112 Moscow, Testovskaya str., 10, entrance 2

Manufacturing and "R&D"

601125 Vladimirskaya oblast, Volginskiy, Zavodskaya str., building 273

Skip